Boeing, Intellia Therapeutics, Royal Caribbean and extra

Check out the companies that are making headlines in midday trading.

Intellia Therapeutics – Intellia shares rose 50% after the company announced positive results from a Phase 1 study with partner Regeneron on a gene-editing treatment. The treatment marks the first time the CRISPR gene editing technique has been administered systemically as a drug to the human body. Other companies involved in CRISPR also rallied, with CRISPR Therapeutics stock rising 6.4% and Editas Medicine stock rising 5%.

Boeing – Shares fell 3.4% after the Federal Aviation Administration wrote in a letter to the aircraft maker that its 777X long-haul aircraft are unlikely to be certified to fly until mid-late 2023 at the earliest. The FAA letter to Boeing received from CNBC stated that numerous technical problems had to be resolved.

Cruise stocks – Cruises may be back, but cruise ship stocks are falling after two teenage guests tested positive for Covid-19 on one of Royal Caribbean’s ships. Royal Caribbean was down 6.4% on Monday, while Carnival was down 7% and Norwegian Cruise was down 6%.

Oil stocks – Oil stocks fell as West Texas Intermediate crude oil futures fell Monday after rising more than 10% in June. Occidental Petroleum was down 5%, Marathon Oil was down 4.8%, Devon Energy was down 4.5%, and Chevron was down 3%.

Tesla – Shares rose 2.5% after Wedbush said the company faced a “moment of truth” following a recall of autopilot software in China. The company maintained its outperformance rating for the electric vehicle maker despite the negative headlines.

Nvidia – The semiconductor maker saw equity rise 4.9% after receiving support for its proposed $ 40 billion acquisition of British chip designer Arm, according to a report in the London Sunday Times. Public support comes from Broadcom, Marvell, and MediaTek, all of Arm’s customers.

NRG Energy – Utility stock rose 5% after Goldman Sachs added NRG Energy to its condemnation list. The company said in a release to its customers that NRG’s strong cash flow profile could allow the company to buy back nearly a quarter of its shares.

Perion Network – Shares rose 18% after the Israel-based ad tech company reported better-than-expected preliminary results for the second quarter. The company reported preliminary revenue of $ 105 million for the second quarter, compared to analysts’ forecast of $ 95.9 million, FactSet said.

Bed Bath & Beyond – The retailer’s stock traded more than 8.7% higher after CFRA Research upgraded it from Hold to Buy. CFRA said it was maintaining a target price of $ 40, implying an upside of nearly 40%.

– CNBC’s Jesse Pound, Tom Franck and Tanaya Macheel contributed to the coverage

Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to get started Try it for free today

Comments are closed.